0001693559-18-000001.txt : 20180611 0001693559-18-000001.hdr.sgml : 20180611 20180611132612 ACCESSION NUMBER: 0001693559-18-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180611 DATE AS OF CHANGE: 20180611 EFFECTIVENESS DATE: 20180611 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Metera Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001693559 IRS NUMBER: 812960607 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-277409 FILM NUMBER: 18891591 BUSINESS ADDRESS: STREET 1: 25 RANDLETT PARK CITY: NEWTON STATE: MA ZIP: 02465 BUSINESS PHONE: 617-312-5367 MAIL ADDRESS: STREET 1: 25 RANDLETT PARK CITY: NEWTON STATE: MA ZIP: 02465 D/A 1 primary_doc.xml X0708 D/A LIVE 0001693559 Metera Pharmaceuticals Inc. 240 Elm Street 2nd Floor Somerville MA MASSACHUSETTS 02144 617-312-5367 DELAWARE None None Corporation true 2016 Marc Lenburg, Ph.D. c/o Metera Pharmaceuticals Inc. 240 Elm Street, 2nd Floor Somerville MA MASSACHUSETTS 02144 Executive Officer Director Meredith C. Fisher, Ph.D. c/o Metera Pharmaceuticals Inc. 240 Elm Street, 2nd Floor Somerville MA MASSACHUSETTS 02144 Director Biotechnology Decline to Disclose 06b true 0001693559-16-000001 2016-12-15 true true Convertible Debt false 0 8550000 8550000 0 false 1 0 0 0 false Metera Pharmaceuticals Inc. /s/ Marc Lenburg, Ph.D. Marc Lenburg, Ph.D. President 2018-06-11